February 11, 2016
(TheTruthAboutCancer.com) Mainstream medicine and drug maker Bristol-Myers Squibb (BMS) are touting BMS’s new cancer drug Opdivo (nivolumab) as a “breakthrough” that offers the hope of longer life. A closer look reveals just how cruel and deceptive such claims are and how the new drug, rather than being a new breakthrough, is just one more example of mainstream medicine’s false promises and an indictment of the mainstream medicine’s failure in treating cancer.
[Sponsor Links: Healing Cancer Protocol]
One prominently featured TV ad utilizes an attractive view of Chicago as a backdrop and smiling healthy looking actors portraying lung cancer patients. The ad boldly proclaims that Opdivo is a huge breakthrough which works with the patient’s own immune system to “at last offer the hope for longer life” for chemotherapy patients.
Another overblown advertisement for Opdivo proclaims:
Researchers have made what looks like a “once in a generation” breakthrough in fighting cancer, advancing a technique that could become one of the “pillars of oncology,” next to surgery and chemotherapy. The technique enables the immune system, which ordinarily treats malignant cancer cells as if they were healthy, normal cells, to identify and attack tumors.
Read the rest of this great article and then please go to UtopiaSilver.com for great supplements and protocols–>
